COMBINATION CHEMOTHERAPY WITH BEVACIZUMAB, DOCETAXEL AND CARBOPLATIN FOR CHEMOTHERAPY-NAIVE PATIENTS WITH NON-SQUAMOUS CELL LUNG CARCINOMA: PHASE II STUDY.

被引:0
|
作者
Matsumoto, Masaru [1 ]
Takiguchi, Yuichi [2 ]
Minato, Kouichi [3 ]
Yoshimori, Kozo [4 ]
Okamoto, Hiroaki [5 ]
Kuribayashi, Hidehiko [6 ]
Ando, Masahiro [7 ]
Shingyoji, Masato [8 ]
Noro, Rintaro [9 ]
Gemma, Akihiko [9 ]
机构
[1] Nippon Med Sch, Grad Sch Med, Dept Pulm Med & Oncol, Tokyo, Japan
[2] Chiba Univ Hosp, Chiba, Japan
[3] Gunma Prefectural Canc Ctr, Ota, Japan
[4] Fukujuji Hosp, AntiTB Assoc, Tokyo, Japan
[5] Yokohama Municipal Citizens Hosp, Dept Resp Med & Med Oncol, Yokohama, Kanagawa, Japan
[6] Chiba Hokusoh Hosp, Nippon Med Sch, Chiba, Japan
[7] Tsuboi Canc Ctr, Fukushima, Japan
[8] Chiba Canc Ctr, Dept Thorac Dis, Chiba, Japan
[9] Nippon Med Sch, Dept Pulm Med & Oncol, Tokyo, Japan
关键词
non-squamous non-small cell lung cancer; Bevacizumab; first line chemotherapy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P3.10-045
引用
收藏
页码:S1177 / S1178
页数:2
相关论文
共 50 条
  • [1] Phase II study of carboplatin, docetaxel and bevacizumab for chemotherapy-naive patients with advanced non-squamous non-small cell lung cancer
    Takiguchi, Yuichi
    Iwasawa, Shunichiro
    Minato, Koichi
    Miura, Yosuke
    Gemma, Akihiko
    Noro, Rintaro
    Yoshimori, Kozo
    Shingyoji, Masato
    Hino, Mitsunori
    Ando, Masahiro
    Okamoto, Hiroaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (04) : 659 - 667
  • [2] A phase I/II study of erlotinib, carboplatin, pemetrexed and bevacizumab in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer harboring EGFR mutations
    Yokoi, T.
    Kurata, T.
    Torii, Y.
    Katashiba, Y.
    Satsutani, N. M.
    Nomura, S.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S637 - S638
  • [3] Phase II study of carboplatin, docetaxel and bevacizumab for chemotherapy-naïve patients with advanced non-squamous non-small cell lung cancer
    Yuichi Takiguchi
    Shunichiro Iwasawa
    Koichi Minato
    Yosuke Miura
    Akihiko Gemma
    Rintaro Noro
    Kozo Yoshimori
    Masato Shingyoji
    Mitsunori Hino
    Masahiro Ando
    Hiroaki Okamoto
    International Journal of Clinical Oncology, 2015, 20 : 659 - 667
  • [4] The phase II study of docetaxel and carboplatin combination chemotherapy for advanced/recurrent patients with non-squamous uterine cervical cancer
    Shoji, T.
    Shimada, M.
    Nagao, S.
    Fujiwara, K.
    Otsuki, T.
    Takano, T. T.
    Murakami, A.
    Sugiyama, T.
    Kigawa, J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S741 - S741
  • [5] A phase II trial of gemcitabine and docetaxel in patients with chemotherapy-naive, advanced nonsmall cell lung carcinoma
    Popa, IE
    Stewart, K
    Smith, FP
    Rizvi, NA
    CANCER, 2002, 95 (08) : 1714 - 1719
  • [6] Docetaxel and carboplatin chemotherapy for treating patients with stage IVB or recurrent non-squamous cell carcinoma of the uterine cervix: a phase II study
    Muneaki Shimada
    Shinya Sato
    Tadahiro Shoji
    Shoji Nagao
    Hideki Tokunaga
    Kotaro Sueoka
    Kazuhiro Takehara
    Keiichiro Nakamura
    Satoshi Yamaguchi
    Junzo Kigawa
    International Journal of Clinical Oncology, 2021, 26 : 1314 - 1321
  • [7] Docetaxel and carboplatin chemotherapy for treating patients with stage IVB or recurrent non-squamous cell carcinoma of the uterine cervix: a phase II study
    Shimada, Muneaki
    Sato, Shinya
    Shoji, Tadahiro
    Nagao, Shoji
    Tokunaga, Hideki
    Sueoka, Kotaro
    Takehara, Kazuhiro
    Nakamura, Keiichiro
    Yamaguchi, Satoshi
    Kigawa, Junzo
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (07) : 1314 - 1321
  • [8] A Galician Lung Cancer Group phase II study of bevacizumab (B), cisplatin, and vinorelbine in chemotherapy-naive patients (p) with non-squamous non-small cell lung cancer (NSCLC)
    Leon, L.
    Vazquez, S.
    Gracia, J.
    Casal, J.
    Lazaro, M.
    Firvida, J. L.
    Amenedo, M.
    santome, L.
    Cardona, J. V.
    Macia, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] Pilot phase II study of metronomic chemotherapy in combination with bevacizumab in patients with advanced non-squamous non-small cell lung cancer
    Jones, Benjamin S.
    Jerome, Mary S.
    Miley, Deborah
    Jackson, Bradford E.
    DeShazo, Mollie R.
    Reddy, Vishnu V. B.
    Singh, Karan P.
    Brown, Olivia C.
    Robert, Francisco
    LUNG CANCER, 2017, 106 : 125 - 130
  • [10] Phase II study of docetaxel alternating with cisplatin in chemotherapy-naive patients with advanced non-small cell lung cancer
    Mattson, K
    Vansteenkiste, J
    Stupp, R
    Bargetzi, M
    Saarinen, A
    Jekunen, A
    Fillet, G
    Teixeira, M
    Gatzemeier, U
    Olivares, R
    Soussan-Lazard, K
    Bérille, J
    ANTI-CANCER DRUGS, 2000, 11 (01) : 7 - 13